Optogenetic Immunotherapy Patent EP4069728A1 - University of Massachusetts
Summary
The European Patent Office published patent application EP4069728A1 for compositions and methods related to optogenetic immunotherapy on April 15, 2026. The applicants are University of Massachusetts, with inventors HAN, Gang and ZHOU, Yubin. The published application covers IPC classifications including C07K, C12N, and A61P therapeutic categories, designating all EPO member states for potential patent protection.
About this source
GovPing monitors EPO Patent Bulletin - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 53 changes logged to date.
What changed
The European Patent Office published patent application EP4069728A1 on April 15, 2026, covering compositions and methods for optogenetic immunotherapy. The application designates all EPO member states (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR) for potential patent protection.
Competitors developing optogenetic or cellular immunotherapy technologies should review the published claims for potential overlap with their own R&D programs. The publication establishes priority rights for University of Massachusetts as of the filing date, and the 18-month examination period will determine whether the patent proceeds to grant.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS AND METHODS FOR OPTOGENETIC IMMUNOTHERAPY
Publication EP4069728A1 Kind: A1 Apr 15, 2026
Applicants
University of Massachusetts
Inventors
HAN, Gang, ZHOU, Yubin
IPC Classifications
C07K 14/705 20060101AFI20231117BHEP C07K 14/725 20060101ALI20231117BHEP C07K 16/00 20060101ALI20231117BHEP C12N 5/0783 20100101ALI20231117BHEP A61P 35/00 20060101ALI20231117BHEP A61K 39/00 20060101ALI20231117BHEP B82Y 20/00 20110101ALI20231117BHEP C07K 16/28 20060101ALI20231117BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.